VCANBIO USA and VCANBIO Center for Translational Biotechnology Launch in the United States

Thursday, September 8, 2016 12:01 PM UTC

NATICK, Mass., Sept. 08, 2016 -- VCANBIO USA Co. Ltd. (VCANBIO USA) and VCANBIO Center for Translational Biotechnology (VCANBIO CTB) today announced that they will host an opening ceremony to celebrate the launch of U.S. operations as subsidiaries of VCANBIO Cell & Engineering Corporation Ltd. (VCANBIO), a company focused on cell therapy and precision medicine.

“Expanding operations into the United States is a momentous occasion for VCANBIO, the largest Chinese biotechnology company and the first company to offer cord blood storage in China,” said Yong Wang, Chairman of VCANBIO USA and VCANBIO Center for Translational Biotechnology. “VCANBIO USA focuses on investing in cell and immunotherapies, while VCANBIO Center for Translational Biotechnology functions as a service entity that fosters partnerships to advance promising new therapies. We are eager to begin building relationships and contributing to the robust biotech community in Massachusetts and the larger United States.”

Following are details of the opening ceremony.


What:			Ribbon-cutting ceremony, lunch and tour of VCANBIO CTB’s lab

Who:			Rep. David P. Linsky (D), State Representative for the 5^th Middlesex House District
			Jijun Xing, the Counselor Consul of Science and Technology Affairs, the Consulate General of the People’s Republic of China in New York
			Defu Li, Chairman of VCANBIO’s board of directors
			Yong Wang, Vice Chairman of VCANBIO’s board of directors
			Dr. MingYuan Wu, Chief Executive Officer of VCANBIO
			Dr. John Lu, President and Chief Executive Officer of VCANBIO CTB

When:			Saturday, September 10, 2016, 11:30 a.m. to 3 p.m.

Where:			VCANBIO USA and VCANBIO CTB corporate office
			21 Strathmore Road
			Natick, MA 01760

RSVP:			If you are a journalist interested in attending the event, please contact Eric Chen at [email protected].

The ceremony will continue in the evening with a celebratory dinner at the Museum of Fine Arts in Boston.

About VCANBIO USA and VCANBIO Center for Translational Biotechnology

VCANBIO USA Co. Ltd. and VCANBIO Center for Translational Biotechnology are U.S. subsidiaries owned by VCANBIO Cell & Engineering Corporation Ltd. VCANBIO USA is focused on investing in cell and immunotherapies in North America. VCANBIO CTB is a service entity that identifies promising new therapies at various stages of clinical translation and provides partners with the expertise and resources necessary to efficiently develop the therapies. VCANBIO CTB’s scientific advisory board is comprised of esteemed scientists with expertise in stem cells, hematology, cancer and more. The companies’ corporate offices and labs are located in Natick, MA.

CONTACT:
Eric Chen
(518) 256-7558
[email protected]

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

VCANBIO USA and VCANBIO Center for Translational Biotechnology Launch in the United States

Editor's Picks

Welcome to EconoTimes